全球生物製藥物流市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計生物製藥物流市場將從 2025 年的 1,665.9 億美元成長到 2034 年的 3,275.1 億美元，2026 年至 2034 年的複合年成長率為 7.8%。

隨著製藥和生物技術產業的持續成長，全球生物製藥物流市場也不斷擴張。生物製藥物流涵蓋對溫度敏感的藥品、疫苗和生物製藥的儲存、處理和運輸。嚴格的溫度控制和合規性對於確保這些敏感醫療產品的安全性和有效性至關重要。

市場成長主要受全球對生物製藥、疫苗和先進治療方法的需求不斷成長所驅動。製藥生產的擴張和醫療供應鏈的全球化，使得對專業物流解決方案的需求日益增加。此外，低溫運輸技術和監控系統的進步，也提高了生物製藥運輸的可靠性和效率。

隨著對生物製藥和個人化藥物的需求不斷成長，生物製藥物流市場預計將迎來顯著成長。物流供應商正投資於先進的低溫運輸基礎設施和數位化監控技術，以確保產品完整性。隨著全球醫療保健體系的擴展和藥物創新技術的進步，該市場有望實現強勁成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生物製藥物流市場：依產品類型分類

• 市場分析、洞察與預測
• 低溫運輸物流
• 非低溫運輸物流

第5章 全球生物製藥物流市場：依運輸服務類型分類

• 市場分析、洞察與預測
• 運輸方式（空運、海運、陸運）
• 倉庫和存儲

第6章 全球生物製藥物流市場：依最終用戶分類

• 市場分析、洞察與預測
• 製藥
• 生物製藥
• 藥局
• 醫院
• 診所
• 超級市場
• 其他

第7章 全球生物製藥物流市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Panalpina World Transport Ltd
  • United Parcel Service Inc
  • XPO Logistics Inc
  • Kuehne+Nagel International AG
  • Fedex Corporation
  • CH Robinson Worldwide Inc
  • Panalpina Group
  • Deutsche Post DHL Group
  • Amerisource Bergen Corporation
  • Ceva Logistics LLC,

The Biopharmaceutical Logistic Market size is expected to reach USD 327.51 Billion in 2034 from USD 166.59 Billion (2025) growing at a CAGR of 7.8% during 2026-2034.

The Global Biopharmaceutical Logistic Market is expanding as the pharmaceutical and biotechnology industries continue to grow. Biopharmaceutical logistics involves the storage, handling, and transportation of temperature-sensitive drugs, vaccines, and biological products. Maintaining strict temperature control and regulatory compliance is essential to ensure the safety and effectiveness of these sensitive healthcare products.

Market growth is driven by increasing global demand for biologic drugs, vaccines, and advanced therapies. The expansion of pharmaceutical manufacturing and the globalization of healthcare supply chains are increasing the need for specialized logistics solutions. In addition, advancements in cold chain technologies and monitoring systems are improving the reliability and efficiency of biopharmaceutical transportation.

In the future, the biopharmaceutical logistics market is expected to grow significantly as the demand for biologic medicines and personalized therapies increases. Logistics providers are investing in advanced cold chain infrastructure and digital monitoring technologies to ensure product integrity. With the expansion of global healthcare systems and pharmaceutical innovation, the market is likely to experience strong growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products Type

• Cold Chain Logistics
• Non-Cold Chain Logistics

By Transport Service Type

• Transportation (Air Freight, Sea Freight, Overland Transportation)
• Warehouse And Storage

By End Users

• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets
• Others

COMPANIES PROFILED

• Panalpina World Transport Ltd, United Parcel Service Inc, XPO Logistics Inc, Kuehne Nagel International AG, Fedex Corporation, CH Robinson Worldwide Inc, Panalpina Group, Deutsche Post DHL Group, Amerisource Bergen Corporation, Ceva Logistics LLC,
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY PRODUCTS TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products Type
• 4.2. Cold Chain Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-Cold Chain Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY TRANSPORT SERVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Transport Service Type
• 5.2. Transportation (Air Freight, Sea Freight, Overland Transportation) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Warehouse And Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY END USERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Users
• 6.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biopharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Products Type
  • 7.2.2 By Transport Service Type
  • 7.2.3 By End Users
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Products Type
  • 7.3.2 By Transport Service Type
  • 7.3.3 By End Users
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Products Type
  • 7.4.2 By Transport Service Type
  • 7.4.3 By End Users
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Products Type
  • 7.5.2 By Transport Service Type
  • 7.5.3 By End Users
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Products Type
  • 7.6.2 By Transport Service Type
  • 7.6.3 By End Users
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPHARMACEUTICAL LOGISTIC INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Panalpina World Transport Ltd
  • 9.2.2 United Parcel Service Inc
  • 9.2.3 XPO Logistics Inc
  • 9.2.4 Kuehne + Nagel International AG
  • 9.2.5 Fedex Corporation
  • 9.2.6 C.H. Robinson Worldwide Inc
  • 9.2.7 Panalpina Group
  • 9.2.8 Deutsche Post DHL Group
  • 9.2.9 Amerisource Bergen Corporation
  • 9.2.10 Ceva Logistics LLC,